SIL-204

N/A

Report date: 2025/06/09 16:50:42
NME

Base Information

Drug NameSIL-204
Drug Alias NameAntisense K-ras RNA gene therapyk-ras基因反义RNA基因治疗siG12D-LODERKRASG12D-LODERSIL-204
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionKRAS G12D inhibitors
TargetsKRAS G12D
Therapy Area/IndicationsPancreatic NeoplasmsColorectal NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsraelCayman Islands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilexion Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSilexion Therapeutics LtdCatalent Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal

Other Information

ATC CodeN/A
Related LinksN/A